These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35683366)

  • 1. Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?
    Sindone A; Doehner W; Manito N; McDonagh T; Cohen-Solal A; Damy T; Núñez J; Pfister O; van der Meer P; Comin-Colet J
    J Clin Med; 2022 May; 11(11):. PubMed ID: 35683366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron Deficiency in Heart Failure: A Korea-Oriented Review.
    Jankowska EA; Ponikowski P
    Int J Heart Fail; 2023 Oct; 5(4):173-183. PubMed ID: 37937204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure.
    Ponikowski P; Kirwan BA; Anker SD; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Haboubi T; Keren A; Khintibidze I; Kragten H; Martinez FA; McDonagh T; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Jankowska EA
    Eur J Heart Fail; 2019 Dec; 21(12):1651-1658. PubMed ID: 31883356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice.
    McDonagh T; Damy T; Doehner W; Lam CSP; Sindone A; van der Meer P; Cohen-Solal A; Kindermann I; Manito N; Pfister O; Pohjantähti-Maaroos H; Taylor J; Comin-Colet J
    Eur J Heart Fail; 2018 Dec; 20(12):1664-1672. PubMed ID: 30311713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry.
    Becher PM; Schrage B; Benson L; Fudim M; Corovic Cabrera C; Dahlström U; Rosano GMC; Jankowska EA; Anker SD; Lund LH; Savarese G
    Eur J Heart Fail; 2021 Nov; 23(11):1844-1854. PubMed ID: 34476878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron replacement therapy in heart failure: a literature review.
    Ismahel H; Ismahel N
    Egypt Heart J; 2021 Sep; 73(1):85. PubMed ID: 34568981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.
    Anker SD; Kirwan BA; van Veldhuisen DJ; Filippatos G; Comin-Colet J; Ruschitzka F; Lüscher TF; Arutyunov GP; Motro M; Mori C; Roubert B; Pocock SJ; Ponikowski P
    Eur J Heart Fail; 2018 Jan; 20(1):125-133. PubMed ID: 28436136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Audit of Iron Deficiency in Hospitalised Heart Failure Patients: A Commonly Neglected Comorbidity.
    AlAayedi K
    Cureus; 2023 Jul; 15(7):e41515. PubMed ID: 37551218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Deficiency: A New Target for Patients With Heart Failure.
    Rizzo C; Carbonara R; Ruggieri R; Passantino A; Scrutinio D
    Front Cardiovasc Med; 2021; 8():709872. PubMed ID: 34447793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis of intravenous iron-carbohydrate complexes in HFrEF patients with iron deficiency.
    Sindone A; Doehner W; Comin-Colet J
    ESC Heart Fail; 2023 Feb; 10(1):44-56. PubMed ID: 36178088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design.
    Mentz RJ; Ambrosy AP; Ezekowitz JA; Lewis GD; Butler J; Wong YW; De Pasquale CG; Troughton RW; O'Meara E; Rockhold FW; Garg J; Samsky MD; Leloudis D; Dugan M; Mundy LM; Hernandez AF;
    Circ Heart Fail; 2021 May; 14(5):e008100. PubMed ID: 34003690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expert consensus regarding treatment of iron deficiency in stable and decompensated patients with heart failure].
    Mareev YV; Gilarevsky SR; Begrambekova YL; Lopatin YM; Garganeeva AA; Duplyakov DV; Kobalava ZD; Golukhova EZ; Koziolova NA; Panov АV; Lelyavina ТА; Drapkina OM; Mareev VY
    Kardiologiia; 2021 May; 61(4):73-78. PubMed ID: 33998412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.
    López-Vilella R; Lozano-Edo S; Arenas Martín P; Jover-Pastor P; Ezzitouny M; Sorolla Romero J; Calvo Asensio M; Martínez-Solé J; Guerrero Cervera B; Sánchez Martínez JC; Donoso Trenado V; Sánchez-Lázaro I; Martinez Dolz L; Almenar Bonet L
    ESC Heart Fail; 2022 Feb; 9(1):133-145. PubMed ID: 34964300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis.
    Rangwala BS; Zuhair V; Mustafa MS; Mussarat A; Khan AW; Danish F; Fatima Zaidi SM; Rehman FU; Shafique MA
    Future Sci OA; 2024 Dec; 10(1):2367956. PubMed ID: 38982752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency.
    Ponikowski P; van Veldhuisen DJ; Comin-Colet J; Ertl G; Komajda M; Mareev V; McDonagh TA; Parkhomenko A; Tavazzi L; Levesque V; Mori C; Roubert B; Filippatos G; Ruschitzka F; Anker SD
    ESC Heart Fail; 2014 Sep; 1(1):52-58. PubMed ID: 28834668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.
    van Veldhuisen DJ; Ponikowski P; van der Meer P; Metra M; Böhm M; Doletsky A; Voors AA; Macdougall IC; Anker SD; Roubert B; Zakin L; Cohen-Solal A;
    Circulation; 2017 Oct; 136(15):1374-1383. PubMed ID: 28701470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Ferric Carboxymaltose Supplementation in Patients with Heart Failure with Preserved Ejection Fraction: Role of Attenuated Oxidative Stress and Improved Endothelial Function.
    Mollace A; Macrì R; Mollace R; Tavernese A; Gliozzi M; Musolino V; Carresi C; Maiuolo J; Nicita M; Caminiti R; Paone S; Barillà F; Volterrani M; Mollace V
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaemia, iron deficiency and heart failure in 2020: facts and numbers.
    Chopra VK; Anker SD
    ESC Heart Fail; 2020 Oct; 7(5):2007-2011. PubMed ID: 32602663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial.
    Filippatos G; Farmakis D; Colet JC; Dickstein K; Lüscher TF; Willenheimer R; Parissis J; Gaudesius G; Mori C; von Eisenhart Rothe B; Greenlaw N; Ford I; Ponikowski P; Anker SD
    Eur J Heart Fail; 2013 Nov; 15(11):1267-76. PubMed ID: 23787722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferric Carboxymaltose in Patients with Acute Decompensated Heart Failure and Iron Deficiency: A Real-Life Study.
    Capone F; Cipriani A; Molinari L; Noale M; Gusella B; Lucente F; Savino S; Bertomoro A; Saller A; Giannini S; Vettor R
    J Pers Med; 2023 Aug; 13(8):. PubMed ID: 37623500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.